HSTM.NASDAQHealthstream INC

Form 4: HealthStream SVP Kevin O'Hara Sells 3,000 Shares

Sentiment:

SEC Form 4 Filing


HealthStream's Senior Vice President, Kevin P. O'Hara, sold 3,000 shares of common stock at a price of $28.03 on August 7, 2024.

Summary

  • On August 7, 2024, Kevin P. O'Hara, a Senior Vice President at HealthStream Inc. (HSTM), sold 3,000 shares of HealthStream common stock.
  • The sale was executed at a price of $28.03 per share.
  • Following the transaction, O'Hara directly owns 9,527 shares of HealthStream common stock.

Sentiment

Score: 5

Explanation: The document itself is neutral as it simply reports a transaction. The sentiment depends on the investor's interpretation of the sale, which could be slightly negative if viewed as a lack of confidence, or neutral if seen as routine.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders (officers, directors, or those holding more than 10% of a company's shares) buy or sell their company's stock. These filings are closely watched by investors as they can provide insights into management's perspective on the company's valuation and future prospects. However, insider sales don't always indicate a negative outlook, as they can be motivated by personal financial planning needs.

Comparison to Industry Standards

  • Comparing this transaction to similar insider sales at comparable companies like Skillsoft or Cornerstone OnDemand would require analyzing their respective Form 4 filings.
  • Generally, the impact of such sales depends on the size of the transaction relative to the insider's total holdings and the overall market sentiment towards the company.
  • A sale of 3,000 shares may be considered relatively small depending on O'Hara's total compensation and investment portfolio.

Stakeholder Impact

  • The sale could have a minor psychological impact on shareholders, depending on how they interpret the insider's actions.
  • The impact on employees, customers, suppliers, and creditors is likely to be negligible.

Key Dates

DateDescription
08/07/2024Date of the stock sale transaction.
08/09/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.